Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.98 USD | -2.15% | -2.22% | +7.33% |
May. 22 | Argus Research Adjusts Price Target on MetLife to $80 From $77 | MT |
May. 10 | Jones Lang LaSalle Arranges $735 Million Term Loan to Refinance Swan and Dolphin Resort | MT |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Its low valuation, with P/E ratio at 9.13 and 7.72 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company has a low valuation given the cash flows generated by its activity.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- One of the major weak points of the company is its financial situation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.33% | 50.48B | B+ | ||
+12.78% | 79.86B | B- | ||
+5.77% | 49.58B | B | ||
+22.23% | 47.13B | B+ | ||
+13.52% | 42.27B | B+ | ||
+22.85% | 39.7B | B | ||
+0.35% | 29.38B | B | ||
-3.83% | 28.85B | B- | ||
-15.03% | 26.79B | A- | ||
+24.15% | 25.88B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MET Stock
- Ratings MetLife, Inc.